CRISPR Interference (CRISPRi) Library

Reversible Gene Silencing for Precise Expression Regulation

Precise gene expression control is key to understanding function, disease mechanisms, and pathways. Traditional KO creates an irreversible "all-or-nothing" loss that cannot reveal dosage effects or enable study of essential genes.

GeneRulor CRISPRi Library Service provides reversible, tunable gene silencing for precise knockdown while maintaining cell viability.

Figure 1 CRISPRi Library Mechanism Diagram

1. What is a CRISPRi Library?

A CRISPRi library uses dCas9 to repress genes by targeting promoter regions without DNA cleavage — enabling reversible, tunable silencing.

2. Core Technical Principles

• Precise Transcriptional Blocking: The dCas9-repressor fusion binds 0-300 bp upstream of TSS, blocking RNA Pol or promoter activation.

• Reversible Regulation: Unlike permanent KO, CRISPRi silencing is reversible via inducible dCas9 systems.

• Dose-Dependent Knockdown: CRISPRi achieves 70-95% knockdown with tunable strength — ideal for essential genes and dosage studies.

• High Specificity: No DNA cleavage means minimal off-target effects — ideal for high-throughput screens.

3. GeneRulor One-Stop Service Advantages — Your Research Accelerator

Traditional CRISPR screens require multi-vendor coordination — adding cost, delays, and quality risks.

Choose Shutong — one decision covers it all. Backed by a postdoctoral R&D team, integrating five departments: Molecular Biology, Cell Biology, Viral Packaging, Bioinformatics, and NGS, we deliver seven end-to-end workflow steps：

4. Five Core Competencies

• Postdoctoral Station, Elite Team: Expert postdoctoral team for library design and data analysis

• Multi-Department Collaboration, Full-Process QC: Integrating Molecular Biology, Cell Biology, Viral Packaging, Bioinformatics, and NGS Sequencing forming a seamless service chain

• Proprietary Design Algorithms, Superior Knockout Efficiency: Proprietary gRNA algorithms achieve 60-90% knockout efficiency

• Professional Viral Packaging Platform for Hard-to-Transfect Cells: High-titer lentivirus for primary cells, neurons, immune cells, and other hard-to-transfect types

• One-Stop Service — Save Time, Effort, and Hassle: Full-cycle service from design to data; no multi-vendor coordination; 30-50% shorter timelines

5. Applications — Reversible Regulation Opens New Research Dimensions

5.1 Essential Gene Function Analysis

Study lethal-when-knocked-out essential genes via tunable knockdown to reveal dosage effects and temporal mechanisms.

5.2 Fine-Tuning Metabolic Pathways

Precisely regulate metabolic enzyme expression to optimize flux — useful in industrial strain engineering and metabolic research.

5.3 Drug Target Validation

Simulate partial inhibition of target proteins to evaluate pharmacological windows and therapeutic potential.

5.4 Gene Regulatory Network Studies

Systematically modulate transcription factors to map regulatory networks and study cell fate and development.

5.5 Host-Pathogen Interaction Studies

Identify host factors required for viral replication or bacterial infection to guide anti-infective therapy development.

6. High-Impact Publication Case Studies

6.1 Case 1: Nature Cell Biology 2025 — CRISPRi Screen Identifies RBM42 as a Key Regulator of MYC-Selective Translation

Reference:

Kovalski et al. (2025). Functional screen identifies RBM42 as a mediator of oncogenic mRNA translation specificity. Nature Cell Biology, 27, 518-529.

Figure 2 CRISPRi Screen Workflow for MYC Selective Translation Regulators

Background: MYC is a key PDAC driver. The team aimed to identify upstream regulators of MYC-selective translation to find druggable nodes.

Approach: CRISPRi screen (dCas9-KRAB) in PDAC cells with MYC translation as readout, plus mechanistic validation.

Key Findings:

• Top hit: RBM42 (RNA-binding protein), overexpressed in PDAC, linked to poor prognosis

• RBM42 regulates translation of MYC and oncogenic transcripts (JUN, EGFR, etc.)

• RBM42 remodels MYC 5' UTR to promote translation initiation

• In vivo: RBM42 is essential for PDAC tumorigenesis (Myc-dependent)

Clinical Significance: CRISPRi identified RBM42 as a druggable translational vulnerability in MYC-dependent tumors.

6.2 Case 2: Cell 2024 — CRISPRi Maps Human Gene Regulatory Networks

Reference: Replogle et al. (2024). Mapping information-rich genotype-phenotype landscapes with genome-scale Perturb-seq. Cell, 185(14), 2559-2575.

Figure 3 CRISPRi + Perturb-seq Gene Regulatory Network Mapping

Background: Understanding how genes cooperate to build cellular networks is a core biology challenge. Traditional methods cannot resolve gene interactions at single-cell resolution at scale.

Approach: The team developed Perturb-seq 2.0, combining CRISPRi with single-cell RNA-seq to perturb 2,500+ genes simultaneously in K562 cells and map high-resolution regulatory networks.

Key Findings:

• 2.5M single-cell transcriptomes — the most comprehensive human gene function map to date

• Gene function is modular — co-regulated genes cluster into functional units

• 1,500+ previously unknown gene interactions identified, including disease-relevant links

• CRISPRi's lower toxicity vs. KO enables long-term single-cell analysis

• ML models predict functions of unperturbed genes, accelerating annotation

Clinical Significance: This established a new paradigm for gene function analysis. Revealing disease gene regulatory networks enables identification of combination therapy targets and drug response prediction.

6.3 Key Insights

These top-journal studies highlight the core value of CRISPRi technology:

• Therapeutic Target Discovery: Reversibility enables discovery of druggable targets missed by KO

• Single-Cell Multi-Omics Integration: Low toxicity enables integration with single-cell sequencing for high-throughput analysis

• Gene Dosage Studies: Tunable repression reveals partial loss-of-function phenotypes closer to disease

• Network Biology: Large-scale perturbations reveal gene interaction networks

GeneRulor's one-stop CRISPRi Service helps your research reach this level — clearing every technical hurdle so you can focus on the science.

7. Technical Advantages Summary

• Genome-wide Coverage: All protein-coding genes in human, mouse, or other organisms; or custom gene sets

• High Knockout Efficiency: NHEJ mutations up to 60-90% efficiency for reliable inactivation

• Stable Phenotype: Permanent modification with stable, heritable phenotypes

• High-Throughput Screening: Thousands of genes evaluated simultaneously

• Cost-Effectiveness: Significantly lower time and cost vs. traditional methods

8. Why Choose GeneRulor?

In functional genomics, technology is a tool. The real value is translating techniques into reliable discoveries. Choose Shutong for a true research partner:

• Postdoctoral R&D station with deep expertise for your project

• Five integrated departments covering every step

• Every project is unique — personalized design, not one-size-fits-all

• Proven platforms and extensive project experience for complex cell types and demands

• Full-process QC and one-stop service from design to data, no multi-vendor hassle

Partner with us to turn your ideas into high-quality research — from top publications to clinical translation.

References

[1] Horlbeck, M. A., et al. (2022). Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors. eLife, 11, e81856.

[2] Horlbeck, M. A., et al. (2016). Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. eLife, 5, e19760.

[3] Gilbert, L. A., et al. (2014). Genome-scale CRISPR-mediated control of gene repression and activation. Cell, 159(3), 647-661.

[4] Qi, L. S., et al. (2013). Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell, 152(5), 1173-1183.